Abstract:A few decades ago, drug discovery and development were limited to a bunch of medicinal chemists working in a lab with enormous amount of testing, validations, and synthetic procedures, all contributing to considerable investments in time and wealth to get one drug out into the clinics. The advancements in computational techniques combined with a boom in multi-omics data led to the development of various bioinformatics/pharmacoinformatics/cheminformatics tools that have helped speed up the drug development process. But with the advent of artificial intelligence (AI), machine learning (ML) and deep learning (DL), the conventional drug discovery process has been further rationalized. Extensive biological data in the form of big data present in various databases across the globe acts as the raw materials for the ML/DL-based approaches and helps in accurate identifications of patterns and models which can be used to identify therapeutically active molecules with much fewer investments on time, workforce and wealth. In this review, we have begun by introducing the general concepts in the drug discovery pipeline, followed by an outline of the fields in the drug discovery process where ML/DL can be utilized. We have also introduced ML and DL along with their applications, various learning methods, and training models used to develop the ML/DL-based algorithms. Furthermore, we have summarized various DL-based tools existing in the public domain with their application in the drug discovery paradigm which includes DL tools for identification of drug targets and drug–target interaction such as DeepCPI, DeepDTA, WideDTA, PADME DeepAffinity, and DeepPocket. Additionally, we have discussed various DL-based models used in protein structure prediction, de novo design of new chemical scaffolds, virtual screening of chemical libraries for hit identification, absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, metabolite prediction, clinical trial design, and oral bioavailability prediction. In the end, we have tried to shed light on some of the successful ML/DL-based models used in the drug discovery and development pipeline while also discussing the current challenges and prospects of the application of DL tools in drug discovery and development. We believe that this review will be useful for medicinal and computational chemists searching for DL tools for use in their drug discovery projects.

Advancing drug discovery with deep attention neural networks

Attention is all you need: utilizing attention in AI-enabled drug discovery

Recent advances and application of generative adversarial networks in drug discovery, development, and targeting

Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review

Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology

Advances in Deep Learning Assisted Drug Discovery Methods: A Self-review

Unlocking the potential of generative AI in drug discovery

Recent Progress of Deep Learning in Drug Discovery

Graph Neural Networks for Drug Discovery: An Integrated Decision Support Pipeline

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design

A Review Of Deep Learning In Computer-Aided Drug Design

Deep Learning in Drug Discovery: Current Landscape and Future Prospects

Multi-layer graph attention neural networks for accurate drug-target interaction mapping

Generative chemistry: drug discovery with deep learning generative models

Meta Learning With Graph Attention Networks for Low-Data Drug Discovery

Deep learning tools for advancing drug discovery and development

The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges

A compact review of progress and prospects of deep learning in drug discovery

De Novo Drug Design Using Transformer-Based Machine Translation and Reinforcement Learning of an Adaptive Monte Carlo Tree Search

Prediction of Drug-Target Affinity Using Attention Neural Network

The rise of deep learning in drug discovery